正路章子 (Ayako Shoji) - マイポータル

基本情報

ORCID iD: https://orcid.org/0000-0002-1077-6393
J-GLOBAL ID: 202401018687745916
researchmap会員ID: R000079874

論文

Cost-effectiveness analysis of bispecific antibody faricimab for treatment of neovascular age-related macular degeneration and diabetic macular edema in Japan

Yasuo Yanagi, Jun Tsujimura, Shinya Ohno, Kentaro Higashi, Naotaka Sakashita, Ayako Shoji, Ataru Igarashi

Journal of Medical Economics 2025年12月31日
The multiple criteria qualitative value-based pricing framework "MARIE" for new clinical status.

Akina Takami, Naotaka Sakashita, Tatsuhiro Uenishi, Ayako Shoji, Ataru Igarashi

Journal of medical economics 28(1) 606-614 2025年12月
The Real World Impact of Immunoglobulin Replacement Therapy on Severe Bacterial Infection for Patients With Hypogammaglobulinemia Secondary to Hematologic Malignancies: A Japanese Claims Database Study

Keichiro Mihara, Takakazu Kawase, Takahiko Miyama, Katsuhiko Iwasaki, Ayako Shoji, Masayuki Matsumaru

eJHaem 2025年8月
Clinical challenges in narcolepsy: From delayed diagnosis to daytime function impairments during treatment.

Yuichi Inoue, Takuya Kumagai, Ayako Shoji, Kinya Kokubo, Makoto Honda

Sleep medicine 131 106496-106496 2025年7月
Clinical characteristics of patients with difficult-to-treat ulcerative colitis: a nested case-control study using a Japanese claims database

Katsuyoshi Matsuoka, Ataru Igarashi, Noriko Sato, Naomi Mizuno, Manabu Ishii, Masato Iizuka, Katsuhiko Iwasaki, Ayako Shoji, Tadakazu Hisamatsu

Intestinal Research 2025年4月25日
Cost-effectiveness analyses to assess the value of reactive atrial-based anti-tachycardia pacing for patients with pacemakers and defibrillators: An Australian private healthcare system perspective.

Adam Gordois, Yuji Tanaka, Tatsuhiro Uenishi, Hiroko Yamaguchi, Ayako Shoji, Michelle Hill

Journal of arrhythmia 41(2) e70043 2025年4月
Characteristics of medical costs and resource use in patients with rheumatoid arthritis treated with and without glucocorticoids.

Eiichi Tanaka, Eisuke Inoue, Ryoko Sakai, Katsuhiko Iwasaki, Ayako Shoji, Masayoshi Harigai

PloS one 20(7) e0329313 2025年
Medical costs for patients with rheumatoid arthritis who have comorbid diabetes mellitus.

Eiichi Tanaka, Eisuke Inoue, Ryoko Sakai, Katsuhiko Iwasaki, Ayako Shoji, Masayoshi Harigai

PloS one 20(8) e0328094 2025年
Reduction in the incidence of cognitive impairment and related costs through an innovative health awareness programme in rural Japan

Ayako Shoji, Kenichi Kudo, Koichi Murashita, Shigeyuki Nakaji, Ataru Igarashi

PLOS ONE 19(10) e0311826 2024年10月14日
Reduction in all-cause medical and caregiving costs through innovative health awareness projects in a rural area in Japan: a retrospective cohort study.

Ayako Shoji, Kennichi Kudo, Koichi Murashita, Shigeyuki Nakaji, Ataru Igarashi

BMC health services research 24(1) 370-370 2024年3月25日
Risk of hospitalized infections in older elderly patients with rheumatoid arthritis treated with tocilizumab or other biological/targeted synthetic disease-modifying antirheumatic drugs: Evaluation of data from a Japanese claims database.

Masayoshi Harigai, Takao Fujii, Ryoko Sakai, Ataru Igarashi, Ayako Shoji, Hiroko Yamaguchi, Katsuhiko Iwasaki, Misako Makishima, Amika Yoshida, Norihiro Okada …

Modern rheumatology 34(2) 287-296 2024年2月26日
Patient-Physician Communication and Perception of Treatment Goals in Rheumatoid Arthritis: An Online Survey of Patients and Physicians.

Shigeki Momohara, Kei Ikeda, Masahiro Tada, Toshiaki Miyamoto, Takanori Mito, Keita Fujimoto, Ayako Shoji, Eriko Wakita, Mitsumasa Kishimoto

Rheumatology and therapy 10(4) 917-931 2023年8月
Cost-effectiveness analysis of cardiac implantable electronic devices with reactive atrial-based antitachycardia pacing

Takashi Noda, Nobuhiko Ueda, Yuji Tanaka, Yoko Ishiguro, Tomoko Matsumoto, Tatsuhiro Uenishi, Hiroko Yamaguchi, Ayako Shoji, Jae-Eun Myung, Kengo Kusano

EP Europace 2023年3月30日
Cost-effectiveness analyses of biologic and targeted synthetic disease-modifying anti-rheumatic diseases in patients with rheumatoid arthritis: Three approaches with a cohort simulation and real-world data.

Masataka Kuwana, Naoto Tamura, Shinsuke Yasuda, Keishi Fujio, Ayako Shoji, Hiroko Yamaguchi, Katsuhiko Iwasaki, Misako Makishima, Yuichi Kawata, Katsuhisa Yamashita …

Modern rheumatology 33(2) 302-311 2023年3月2日
Characteristics of subjects with type 2 diabetes enrolled in randomized controlled trials and non‐randomized controlled trials in Japan: A systematic review

Takashi Kadowaki, Ayako Shoji, Yurie Taguchi

Journal of Diabetes Investigation 14(2) 236-246 2023年2月
Reduction in medical costs for cardiovascular diseases through innovative health awareness projects in a rural area in Japan

Ayako Shoji, Kennichi Kudo, Koichi Murashita, Shigeyuki Nakaji, Ataru Igarashi

PLOS ONE 17(11) e0277600 2022年11月16日
Cost-consequence of abatacept as first-line therapy in Japanese rheumatoid arthritis patients using IORRA real-world data

Eiichi Tanaka, Eisuke Inoue, Ayako Shoji, Jonas Nilsson, Christos Papagiannopoulos, Devender Dhanda, Yuri Yoshizawa, Mai Abe, Kumiko Saka, Eri Sugano …

PLOS ONE 17(11) e0277566 2022年11月16日
Efficacy of Low-Dose Estrogen–Progestins and Progestins in Japanese Women with Dysmenorrhea: A Systematic Review and Network Meta-analysis

Masaru Iwata, Yoshihiro Oikawa, Yutaka Shimizu, Naotaka Sakashita, Ayako Shoji, Ataru Igarashi, Yutaka Osuga

Advances in Therapy 2022年11月
30-year trends of hip and vertebral fracture incidence in Japan: a systematic review and meta-analysis.

Ayako Shoji, Zhenyu Gao, Koichi Arai, Noriko Yoshimura

Journal of bone and mineral metabolism 40(2) 327-336 2022年3月
A Systematic Review and Network Meta-Analysis on the Efficacy of Medications in the Treatment of Chronic Idiopathic Constipation in Japan

Atsushi Nakajima, Ayako Shoji, Kinya Kokubo, Ataru Igarashi

Gastroenterology Research and Practice 2021年11月30日

もっとみる

MISC

日本人血友病患者による身体活動阻害要因評価スケール（Barriers to Being Active Quiz: BBAQ-21）の言語的妥当性の検証

竹谷英之, 白幡聡, 酒井道生, 德川多津子, 岩崎勝彦, 坂下尚孝, 正路章子, 吉原圭亮

日本血栓止血学会誌 34(3) 381-393 2023年
大規模アンケート調査に基づくEQ-5D-5Lを用いた日本のがん患者のQoL評価

山口裕子, 岩崎勝彦, 正路章子, 正路章子, 小久保欣哉, 小久保欣哉, 五十嵐中, 五十嵐中

Therapeutic Research 41(12) 2020年
進行性核上性麻痺の社会的・経済的負担に関する推計

五十嵐中, 五十嵐中, 饗場郁子, 正路章子, 正路章子, 岩崎勝彦, 齋藤快路, CHEN Alice Niann-Woei, 羽山明宏

薬理と治療 48(6) 2020年
経口治療薬服薬中の2型糖尿病患者の残薬に関する調査-残薬有無に影響する要因分析-

寺内康夫, 正路章子, 正路章子, 小久保欣哉, 小久保欣哉

薬理と治療 45(11) 2017年
動脈硬化性疾患予防ガイドライン2012年版におけるスタチンによるコレステロール管理目標到達への影響因子の探索

寺本民生, 小久保欣哉, 小久保欣哉, 正路章子

薬理と治療 42(2) 2014年
2DICAL法にて発見された新規血液バイオマーカー

尾野雅哉, 松原淳一, 本田一文, 佐久間朋寛, 橋口朋代, 能勢博, 増田万里, 高倉美智子, 下重美紀, 桑原秀也 …

日本プロテオーム学会大会要旨集 2009 35-35 2009年

正路章子

基本情報

論文

MISC

メニュー

共著者の一覧